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Abstract—The radiation dose received by the pelvic Bone 
Marrow (BM) is a predictive factor for Hematologic Toxicity (HT) 
occurrence in the treatment of anal cancer. For this reason it is 
important to avoid BM during radiotherapy. In particular, the 
standard strategy in these cases consists in the identification of 
hematopoietically active BM (actBM), i.e. the part of BM in 
charge of blood cells generation, on 18FDG-PET, FLT-PET or 
MRI, but no approached have been developed for identifying 
actBM from CT images. This exploratory study aims to use 
radiomics for detecting actBM on CT sequences. Our approach is 
based on the extraction of 36 first-order and texture (second-
order) features for each CT slice. These features are used as input 
of a Decision Tree (DT) classifier able to discriminate between 
active and inactive BM regions on the images. This method was 
applied to five patients affected by carcinoma of the anal canal and 
the obtained actBM segmentation was compared with the standard 
actBM identification from 18FDG-PET (reference standard, RS). 
Our results show that actBM identification in lumbosacral and 
iliac structures using radiomics overlaps the RS for more than 
75% in 4 out of 5 patients.  
Keywords—texture features, radiomics, decision tree, computed 
tomography (CT), hematopoietically active bone marrow. 
I. INTRODUCTION 
Actually, the standard treatment option for anal cancer 
patients is concurrent chemo-radiation [1]. Despite the use of 
high-tech delivery approaches such as Intensity-Modulated 
Radiation Therapy (IMRT), toxicity remains not negligible. 
Acute Hematologic Toxicity (HT) may affect compliance to 
therapy, increasing the probability to develop asthenia, bleeding, 
or infections [2]. Chemotherapy is the most important trigger for 
HT, but also radiation plays an important role [3]. In adults, 
pelvic bones and lumbar spine contain almost 60% of total Bone 
Marrow (BM) [4]. Since the dose received by the BM comprised 
within the pelvic bones is a predictive factor for HT occurrence, 
a crucial point in radiotherapy is to implement strategies able to 
selectively spare BM, by correctly identifying and delineating 
this structure. Although the use of the whole pelvic bones as 
surrogates is the most inclusive method with respect to BM, 
other strategies have been developed. One consists in selectively 
avoiding the hematopoietically active BM (actBM), that is the 
part of BM in charge of blood cells generation. Several methods 
exist to identify active BM, based on morphological and 
functional imaging[5], such as magnetic resonance imaging 
(MRI), single-positron emission tomography (SPECT), 
fluorodeoxyglucose (18FDG)-labeledor fluorothymidine (FLT)-
labeled positron emission tomography (PET) [6–8]. 18FDG-PET 
is considered an optional exam by international guidelines in the 
diagnostic work-out and hence not all patients have it. 
Computed tomography (CT), however, is a widespread exam 
and all patients have to undergo it before starting 
radiotherapy. Thus, an approach based on CT images to 
define actBM would be very useful and would have a potential 
broader applicability. To the best of our knowledge, no 
approaches have been proposed to identify actBM using CT. 
Radiomics identifies the “process designed to extract a large 
number of quantitative features from digital images” [9]. Its final 
aim is to extract hidden information from images that can be 
useful to develop Computer-Aided Diagnosis (CAD) systems 
and decision support. Since images are processed as matrices of 
data, radiomics can be potentially applied to all kinds of images, 
such as CT, MRI, PET. In the study by Rosati et al. [10] it was 
proved that applying radiomics to carotid ultrasound images 
allows for identifying high cardiovascular risk subjects and 
capturing the progressive development of pathological 
conditions in vessel wall layers. Giannini et al. [11] used 
radiomics to increase specificity of a CAD system for prostate 
cancer detection based on MRI. The basic step of radiomics is 
feature extraction, consisting in the calculation of variables able 
to quantitatively describe the characteristics of the anatomical 
structure of interest. Three main groups of features can be used: 
first-order statistical features, simply describing the statistical 
distribution of the intensities in a given region, second-order or 
texture features, describing the spatial distribution of the 
intensities in a given region, and higher-order features, aiming 
to find specific patterns. 
The aim of this study is to evaluate the feasibility of 
detecting actBM by applying radiomics to CT images. 
II. MATERIALS AND METHODS 
A. Population 
Five patients with locally advanced squamous cell 
carcinoma of the anal canal and/or margin were involved in this 
study, all belonging to the Oncology Dept. institutional 
database. The patients were treated with concurrent chemo-
radiation employing volumetric modulated arc therapy and 
concomitant 5-fluorouracil and mytomicin C. All patients 
underwent 18FDG-PET-CT exam to complete the diagnostic 
and staging work-up, and a non-contrast enhanced CT of the 
pelvic region for planning purposes before the beginning of 
radiotherapy. The study agreed with the ethical principle of the 
Helsinki Declaration and all participants signed a written 
informed consent to be included in the study. 
B. CT and 18FDG-PET acquisition 
For the CT acquisition, patients had a virtual simulation 
procedure in supine position with both an indexed shaped knee 
rest and ankle support (CIVCO Medical Solutions, Kalona, IA, 
USA), without custom immobilization. Planning CT was 
performed according to standard clinical scanning protocols at 
the Oncology Dept. with a Philips ‘‘BigBore’’ CT scanner 
(Philips Medical System, Eindhoven, NL). The most common 
pixel spacing was (0.93 mm, 0.93 mm, 3 mm) for CT. 18FDG -
PET scans were performed with a Philips Gemini PET/CT 
tomography. Data acquisition started 90 min after an 
intravenous injection of approximately 30 MBq/kg body 
weight of 18F-glucose. First, a total body CT scan was 
acquired; then, PET scans of the same area were collected for 
2.5 min/bed position. A dedicated fused imaging workstation 
(Extended Brilliance Workspace 2.0) was adopted for PET 
clinical interpretation. 
C. Reference Standard 
 Bone marrow segmentation on planning CT 
The procedure described in [12] was applied to segment the 
whole pelvic bone marrow (PBM) on the planning CT. Then, 
the PBM was manually divided into three subregions by a 
dedicated radiation oncologist: a) the iliac BM (IBM), 
comprising the area between the iliac crests and the upper border 
of femoral head; b) lower pelvis BM (LPBM), including 
bilateral pube, ischia, acetabula and proximal femura, from the 
upper border of the femoral heads to the lower aspect of the 
ischial tuberosities; c) lumbosacral BM (LSBM), comprising the 
area between the superior border of L5 somatic body to the 
lower aspect of the coccyx. 
 Active bone marrow segmentation on 18FDG-PET 
We exported all images derived from planning CT on the 
VELOCITY platform (Varian Medical Systems, Palo Alto, 
CA), together with treatment volumes, organs at risk (OARs) 
and dose references. Given that 18FDG-PET images were 
acquired separately, a deformable co-registration between CT 
and PET images was performed. Then, we calculated the 18FDG-
PET standardized uptake values (SUVs) for the PBM volume of 
all subjects, after correcting for body weight. To standardize 
SUVs among all patients, we normalized BM and liver SUVs. 
For each patient, we labeled as actBM the portion of PBM 
presenting SUV values higher than the patient mean SUV [8]. 
The difference between PBM and actBM was labeled as inactive 
BM (inactBM). Figure 1 highlights PBM (green line) and actBM 
(red line) as identified with the use of 18FDG-PET in a specific 
patient. The difference between these two areas identified 
inactBM. 
D. Active bone marrow identification using radiomics 
The process starts by removing the cortical bone from the 
regions of interest (ROIs); in the second step the image was 
divided in overlapping 5 by 5 pixels elements and 36 features 
were computed for each element; the third step consisted in the 
training set and classifier construction; pixel classification was 
obtained in the fourth step by means of a voting system; finally 
a post-processing was applied to the identified regions to 
enhance the classification accuracy. All the steps are described 
in details in the following. 
 Removal of cortical bone 
From the whole PBM volume, we removed the cortical bone 
since it less likely contains BM. For this purpose, we processed 
each CT slice as a single image. First, we applied the k-means 
algorithm with k=2 to the intensities of CT pixels within the 
PBM. Then, since the cortical bone appears lighter than the 
cancellous bone on CT images, we considered as cortical bone 
the cluster with the highest mean intensity and removed these 
pixels from the ROIs. This step allowed us to keep only the 
cancellous bone. 
 Feature Extraction from cancellous ROIs 
The remaining ROIs belonging to PBM were analyzed using 
radiomics. In particular, we considered an element made of 5-
by-5 pixels. Subsequent elements were obtained moving by 1 
pixel at time in both directions across the CT slice. For all 
elements overlapping bone marrow ROIs, a set of 36 features 
was calculated: 4 first-order statistical features (mean, standard 
deviation, skewness and kurtosis of the pixels intensities) and 32 
second-order (texture) features. We calculated 22 texture 
features from the grey-level co-occurrence matrices (GLCM) 
[13], that counts the number of occurrences for which a pixel 
with a gray level i appears at specific distance from a pixel with 
grey level j, in a given direction. Starting from the GLCM, we 
calculated the following variables: autocorrelation [14], contrast 
[14], correlation1 [15],  correlation2 [14], cluster prominence 
[14], cluster shade [14], dissimilarity [14], energy [14], entropy 
[14], homogeneity1 [15], homogeneity2 [14], maximum 
probability [14], sum of squares [13], variance [13], sum 
average [13], sum variance [13], sum entropy [13], difference 
variance [13], difference entropy [13], information measure of 
correlation1 [13], information measure of correlation2 [13], 
inverse difference normalized [15], inverse difference moment 
normalized [15]. A set of 5 texture features were obtained from 
the Gray Level Difference Method (GLDM) [16], taking into 
account the difference of the intensities of two pixels at specific 
distance and in a given direction. From this analysis we 
extracted: contrast, angular second moment, entropy, mean, and 
inverse difference moment [16]. Finally, 5 texture features were 
extracted from the Grey-Level Run Length Method (GLRLM) 
[16], counting the number of contiguous pixels with a specific 
grey level in a given direction. In this case, the extracted 
variables were the following: short run emphasis, long run 
emphasis, gray level distribution, run length distribution, and 
run percentage [16]. Since in this application we cannot identify 
a preferential texture direction, the GLCM, GLDM and GLRLM 
were evaluated for the four main directions (0°, 45°, 90°, 135°) 
with a distance of one pixel. Then, the four matrices were 
averaged to extract the texture features. 
 Training Set and Classifier construction 
Taking into account the purpose of this study, that is to 
understand the feasibility of identifying actBM from CT 
imaging, we decided to implement a classifier for each patient. 
First, we constructed a training set for each subject considering 
five slices equispaced across the subject’s CT sequence.   For 
each slice we randomly extracted 1/5 of all valid elements (i.e. 
overlapping bone marrow ROIs). Each element was 
characterized by the 36 features and a label indicating the class 
it belongs to:  active or red marrow (RM) if the element overlaps 
an actBM region obtained from 18FDG-PET, inactive or yellow 
marrow (YM) otherwise. Then, the elements extracted from the 
five slices were pooled together to create a balanced training set 
for each patient. Before constructing the classifier, each training 
set was discretized by means of the Chi2 algorithm [17], in order 
to reduce the effect of noise and improve the classification 
performance [18]. The Chi2 algorithm is a supervised and 
bottom-up discretization method based on the χ2 statistic. For 
each variable to be discretized, firstly elements are sorted in 
ascending order. Then, the algorithm iteratively merges, in a 
discrete interval, those adjacent elements having a class 
independent from the variable values. This discretization 
proceeds until the χ2 value for all adjacent intervals is greater 
than the χ2 value calculated for a give significance level α and 
for a number of degrees of freedom equal to the total number of 
classes minus1. In order to avoid to set a significance level a-
priori, the discretization is performed with decreased α values, 
until the consistency rate of the discrete dataset is above a 
desired value. In particular, we run the Chi2 algorithm for 
significance levels from 0.5 to 0.001 and we used the 
dependency degree [19], based on the Rough Set Theory, as 
consistency measure. The algorithm was stopped when the 
dependency degree of the discrete dataset for a specific α value 
was lower than the one of the original continuous dataset.  
A Decision Tree [20] (DT) for each patient was obtained 
based on correspondent discrete training set. For the classifier 
construction we adopted the CART algorithm [20], while the 
identification of the best splitting rule for each node was based 
on the Gini Index [20].  
 Pixel Classification and Post-processing 
All elements extracted from the bone marrow ROIs of the 
entire CT sequence were firstly discretized using the cut-off 
points obtained from the Chi2 algorithm. Then, they were 
classified in one of the two classes (RM or YM) using the DT 
constructed for the specific subject. Finally, since each pixel was 
included in more than one element, the majority voting was used 
to classify the single pixel: the pixel class was the one that 
appears most often among the including elements. This 
procedure allows for reducing errors due to a single 
classification and to improve the overall accuracy [21].  
Considering only the pixel classified as RM, we obtained a 
binary mask of the actBM for each CT slice. This mask was 
further processed in order to fill small holes and remove very 
small regions. For achieving this objective, we performed a 
morphological closing operation on the binary mask, using a 
disk-shaped structuring element with radius equal to 3.  
E. Validation 
To validate our approach, we compared the actBM 
segmentation obtained from 18FDG-PET (reference standard, 
RS) with those returned by radiomics applied to the CT 
sequences (CT). The comparison was carried out using three 
indices: 
 Dice index, measuring the overall overlap between the two 
segmentations:𝐷𝑖𝑐𝑒 = 2 ∙ (𝑅𝑆 ∩ 𝐶𝑇)/(𝑅𝑆 + 𝐶𝑇) 
 Precision, measuring the over-segmentation:𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =
(𝑅𝑆 ∩ 𝐶𝑇)/𝐶𝑇 
 Recall, measuring the under-segmentation:𝑅𝑒𝑐𝑎𝑙𝑙 = (𝑅𝑆 ∩
𝐶𝑇)/𝑅𝑆 
 Dice, Precision and Recall were calculated for each slice of 
a CT sequence and for the three subregions separately.  
III. RESULTS  
Figure 1 shows an example of segmentation obtained using 
radiomics on CT (yellow dashed line) with the RS delineated 
from 18FDG-PET (red line). 
For each of the 3 subregions we processed a number of slices 
ranging from 30 to 44 for every patient. The mean and standard 
deviation of the three indices are reported in Table I for the five 
patients and the three subregions separately. As it emerges from 
the table, the highest indices values are obtained for LSBM and 
IBM subregions, where we have an overlap between RS and CT 
above 75% in 4 out of 5 patients. The subregion with the lowest 
over-segmentation is the IBM, reaching precision above 80% for 
all patients. For the LPBM, not satisfying results are achieved, 
as the dice index is always below 0.5. However, the recall for 
this structure is higher than 0.7 in 4 out of 5 patients, meaning 
that at least the 70% of the RS segmentation is correctly 
recognized by the DT on CT images. These differences among 
 
Fig. 1. Example of segmentation obtained using radiomics on CT. Green line: 
pelvic bon marrow segmentation. Red line: active bone marrow segmentation 
delineated from 18FDG-PET without cortical bone (reference standard). Yellow 
dashed line: active bone marrow identified using radiomics on the CT image. 
 
the three subregions might be due to the different amount of 
actBM within them, with the LSBM containing almost entirely 
hematopoietically active bone marrow. Moreover, the actBM 
identification in the LPBM might be influenced by the presence 
of the femura. Possible improvements in this direction could be 
obtained by constructing a classifier specific for each subregion, 
so that the characteristics of the three structures can be captured 
more accurately. 
IV. CONCLUSIONS 
This work proposes an exploratory study aiming to 
understand if radiomics is able to identify hematopoietically 
active BM from CT imaging. This is the first study in this 
direction, as the standard strategies for active BM detection are 
based on PET and MRI. Our results are very promising, above 
all for lumbosacral and iliac structures where our approach is 
able to correctly identify more than 75% of actBM. However, it 
is very likely that the obtained results were not bias from the use 
of a specific classifier for each subject, since the number of 
elements included in the training set of each DT was extremely 
lower than the amount of elements to be classified in all CT 
slices. A larger population of patients will be included in future 
studies, to better test the generalization capability of our 
approach. From the feature extraction viewpoint, the use of 
texture features, focusing on the spatial distribution of the pixel 
intensities on the image instead of the single intensity value, 
allows for constructing classifiers that are robust to 
modifications in the acquisition parameters or protocol. Future 
works will be aimed to develop a classifier specific for each 
subregion, that could be applied for all subjects and to explore 
the ability of other classifiers, also in the field of deep learning. 
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TABLE I.  RESULTS OF THE COMPARISON BETWEEN ACTIVE BONE MARROW IDENTIFICATION FROM 18FDG-PET AND CT 
 
IBM LPBM LSBM 
Dice Precision Recall Dice Precision Recall Dice Precision Recall 
Patient #1 0.88 ± 0.12 0.86 ± 0.17 0.93 ± 0.06 0.40 ± 0.19 0.27 ± 0.15 0.86 ± 0.19 0.87 ± 0.16 0.89 ± 0.12 0.87 ± 0.17 
Patient #2 0.83 ± 0.13 0.89 ± 0.11 0.80 ± 0.17 0.36 ± 0.18 0.24 ± 0.15 0.79 ± 0.23 0.75 ± 0.31 0.75 ± 0.35 0.86 ± 0.19 
Patient #3 0.57 ± 0.26 0.80 ± 0.22 0.48 ± 0.26 0.40 ± 0.20 0.37 ± 0.19 0.55 ± 0.27 0.40 ± 0.32 0.74 ± 0.29 0.37 ± 0.33 
Patient #4 0.75 ± 0.18 0.90 ± 0.16 0.66 ± 0.21 0.43 ± 0.18 0.34 ± 0.19 0.72 ± 0.19 0.82 ± 0.22 0.85 ± 0.27 0.82 ± 0.13 
Patient #5 0.93 ± 0.05 0.95 ± 0.07 0.91 ± 0.05 0.42 ± 0.10 0.28 ± 0.11 0.89 ± 0.11 0.78 ± 0.15 0.77 ± 0.21 0.82 ± 0.11 
 
 
